Sana Biotechnology's total assets for Q4 2024 were $501.02M, a decrease of -10.43% from the previous quarter. SANA total liabilities were $250.52M for the fiscal quarter, a -6.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.